Building Clinical and Genetic Data for GP2 in the Cohort Integration Working Group
By Huw Morris | Complex disease genetics |Huw Morris leads the Cohort Integration working group (CIWG). In this blog post, Huw provides an outline of the research on Parkinson’s disease over the last 25 years and shares the plans of the CIWG to harmonize clinical data from research participants to enable large clinical outcomes research.
Understanding GWAS: Part 2 – Additional Insights and Tips
By GP2 Complex Disease Data Analysis Working Group | Complex disease genetics |As a follow-up to the last blog post on Understanding GWAS, the GP2 Complex Disease Data Analysis Working Group has provided practical tips and insights for running your own GWAS.
Understanding GWAS
By GP2 Complex Disease Data Analysis Working Group | Complex disease genetics |Members of the GP2 Complex Disease Data Analysis working group provide an overview of Genome-Wide Association Studies (GWAS), including statistical formulae, workflows, and examples from the most recent Parkinson’s disease GWAS.
Why study disease in different populations?
GP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involving populations currently underserved in disease research.
